Guardant Health's MCD test earns FDA breakthrough designation
This methylation-based blood test is designed for the screening of various types of cancer in people who are 45 or above and are at a typical average cancer risk.
The tested cancers include colorectal, oesophageal, bladder, gastric, lung, liver, pancreas, and ovarian.
The FDA's designation for the MCD test follows its selection by the National Cancer Institute (NCI) for the Vanguard Study assessing the technology.
This test was selected based on its predictive performance for cancer presence and for identifying the origin of the cancer tissue.
At the 2025 American Society for Clinical Oncology Annual Meeting in Illinois, US, Guardant Health presented data from a case-control cohort of the Shield MCD test.
The findings demonstrated the test's specificity and sensitivity, along with accuracy in determining the cancer signal of origin across various types of tumours.
It exhibits 98.6% specificity and 75% sensitivity for detecting cancers, as per the data.
The sensitivity range for individual cancers varied between 62% and 96%, with primary or secondary cancer signal origin accuracy reaching 92%.
The breakthrough device designation is awarded to a select group of medical devices that show potential in treating or diagnosing life-threatening conditions compared to existing options.
Guardant Health co-CEO and co-founder AmirAli Talasaz said: 'Every late-stage cancer we avert is a win for patients and for the entire healthcare system.
'This recognition by the FDA shows the promise of the Shield MCD test to detect multiple cancers at an early stage with just a single, routine blood draw. We look forward to partnering with the agency and other stakeholders to bring this breakthrough to patients quickly.'
Last year, the company expanded its market reach by striking a deal to promote its range of liquid and tissue biopsy tests for cancer screening in the Middle East and North Africa region.
"Guardant Health's MCD test earns FDA breakthrough designation" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
44 minutes ago
- The Hill
Senate Democrat rips Costco for ‘refusing to sell' abortion pills
Sen. Patty Murray (D-Wash.) hammered Costco on Friday for appeasing 'far-right extremists,' after the retailer said earlier this week that its pharmacies would not dispense the abortion medication mifepristone. 'I am deeply alarmed by news reports that Costco is refusing to sell safe, effective, and legal medication for no other reason than to appease the politics of anti-abortion fanatics,' Murray said in a statement following the news. 'I refuse to stand by and allow far-right extremists to bully major corporations and dictate what medicine women can or cannot get access to.' 'Where it is legal, retailers and major pharmacies must absolutely make medication abortion available to the women who need it,' the Washington Democrat added. Costco, in its Thursday announcement, explained that the decision came from a 'lack of demand.' 'Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers,' the company said, according to Reuters. The decision comes after CVS and Walgreens announced last year that they received certification to provide the drug in states where abortion remains legal. Murray pressed Costco to rescind its decision, warning that limiting access to mifepristone, one of two drugs used in medication abortion, is harmful to women's health. 'Mifepristone is safe and effective—we cannot live in a world where the availability of women's health care whipsaws back and forth based on the whims of extremists who want to deny women access to basic health care,' she wrote Friday. 'I am demanding that Costco immediately reverse course—follow the science and the facts, not the demands of far-right anti-abortion extremists.' The Supreme Court in a decision last year ruled unanimously that a group of anti-abortion doctors did not have the legal basis to challenge access to the pill. Despite the ruling, Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary are weighing a review of the abortion pill. Murray questioned Makary during his Senate confirmation hearing on the proposal, as well as President Trump's moves to gut staff at the FDA.
Wall Street Journal
4 hours ago
- Wall Street Journal
What You Need to Know About Kratom
Millions of Americans take the herbal supplement kratom for everything from energy to pain relief to quitting opioids. You can find kratom capsules, powder, drinks and shots in health food stores, gas stations and smoke shops. But the Food and Drug Administration is pushing to effectively ban a kratom derivative known as 7-OH, citing its potential for abuse. Some doctors and substance-abuse counselors warn that there are signs the plant itself is potentially addictive. Users contend it confers pain and mood-related benefits and provides an alternative to opioids.
Forbes
5 hours ago
- Forbes
You May Now Give Yourself A Flu Vaccine At Home With FluMist Home
These days, there are more things that you can do at home by yourself that you couldn't do before such as sit in a business meeting without wearing any pants. Well, here's another thing that previously wasn't possible at home but now is: vaccinate yourself against the flu. Yep, if you are in one of the 34 eligible states in the U.S., you can now get the FluMist Home vaccine from AstraZeneca delivered to right to your home. And in case you missed what FluMist is, it's a nasal spray vaccine. So rather than sticking yourself with a needle, you can simply squirt the vaccine up your nose. FluMist Home Is The Home Version Of FluMist Vaccine The vaccine itself isn't new. The FluMist nasal spray vaccine received U.S. Food and Drug Administration approval back in 2003 to be used for those from five to 49 years of age. The FDA added kids from two through five years of age to this approval in 2007. But until last year, like all other flu vaccines, you had to get some kind of qualified healthcare worker to give you the vaccine. That all changed in September 2024 when the FDA approved FluMist to be the first self-administer-able flu vaccine out there. Not coincidentally, it's also the only nasal spray flu vaccine out there. It's probably a whole lot easier and safer for folks to squirt something up their noses rather than stick their arms with needles. Not surprisingly, AstraZeneca wasn't ready to go with the home version of FluMist, known as FluMist Home, last flu season, which was a particularly nasty one, as I covered in Forbes tat the time. But the company is ready for this upcoming flu season. Starting this fall, if you are an adult under 50 or a parent of a child who's older than two you can order the vaccine via an online platform. Now you will have to complete a medical screening questionnaire that will be reviewed by a licensed healthcare professional before the vaccines gets prescribed to you or your tykes. Most types of commercial insurance should cover this vaccine. But you may have to fork out $8.99 for shipping and handling. Now, if you are an adult 50 years or older or a kid from six months up to two years of age and saying WTF, as in 'what the FluMist,' for me, you aren't eligible for this vaccine. That's because the vaccine uses live (but weakened) versions of the flu virus, which is different from the other flu vaccines that use dead or inactivated versions of the flu virus. The live, weakened versions of the flu virus may generate a stronger immune response and thus stronger protection than the dead versions. However, if you've got a weaker immune systems such as when you get older than 50 or are younger than two years of age, you want to be careful about getting a live virus, even if it is weakened, injected into you. FluMist Home Could Help Increase Flu Vaccination Rates The flu vaccine typically offers anywhere from 30% to 60% protection against the flu, depending on how well the flu strains in the flu vaccine match the circulating strains that year. Since it takes about six months to produce the flu vaccine, the selection of the strains for the vaccine need to occur well in advance of the flu season. That's why sometimes it's a good match, sometimes things are way off and often it's somewhere in between. As with many other vaccines against infectious diseases, how well you are protected against the flu does depend on how many other people around you got vaccinated as well. Last flu season, an estimated 46.7% of adults and 49.2% of children got vaccinated against the flu. That's compared to 49.2% and 53.4% for the flu season prior in 2023-2024, according the Centers for Disease Control and Prevention data. These close-to-but-not-quite-half have been rather typical each flu season recently, as I have written in Forbes previously. Those numbers ain't great. You may have heard of the concept of herd immunity, which I have written about before in Forbes. While the flu vaccine will help protect the individuals who got it, ideally you want the vaccination coverage to be significantly higher than the herd immunity threshold for flu, which is around 50%. When the vaccination coverage is well above the herd immunity threshold, the virus begins to run out of susceptible people to infect, which in turn slows the spread of the flu virus in the population. It's not completely clear why over the half the U.S. population did not get the flu vaccine last flu season. For some, it might have been a matter of convenience. They may have not gotten vaccinated simply because they didn't find the time to take time off from work to go to a clinic or pharmacy. For such folks, having something like FluMist Home available may increase their chances of getting vaccinated.
